NEW YORK — Investors who experienced losses in Hims & Hers Health, Inc., are being urged to explore their legal options by a prominent law firm amid ongoing allegations against the company. Bragar Eagel & Squire, P.C., known for representing shareholders, has announced that a class action lawsuit has been initiated against Hims & Hers in the United States District Court for the Northern District of California.
The lawsuit pertains to those who purchased or acquired Hims securities from April 29 to June 23, 2025, a timeframe designated as the “Class Period.” Interested investors have until August 25, 2025, to seek appointment as lead plaintiff in the case by contacting the firm directly.
The complaint raises serious allegations about the company’s conduct during the Class Period, asserting that the defendants provided misleading statements and failed to disclose significant facts regarding the company’s operations and future prospects. Specifically, it claims that Hims promoted and sold illegitimate versions of the weight-loss drug Wegovy®, endangering patient safety.
Furthermore, the lawsuit alleges that this misleading promotion could jeopardize Hims’ collaboration with Novo Nordisk, the pharmaceutical company behind Wegovy. As a result of these actions and omissions, investors may have been misled about the company’s stability and future growth potential.
The complaint also highlights additional alleged misrepresentations, including assurances from Hims that its relationship with Novo would foster long-term access to Wegovy for its users and promote user choice by providing alternatives on its platform. It suggests that these claims lacked a reasonable foundation and were misleading to shareholders.
Those who bought or acquired Hims shares and experienced losses are encouraged to reach out to Bragar Eagel & Squire. The firm emphasizes that there is no cost or obligation associated with consultations, allowing investors to explore their options freely.
Bragar Eagel & Squire is recognized for its work in representing individuals and institutions in a variety of complex litigation, including securities and commercial disputes. With offices in multiple states, the firm seeks to protect investor rights across the nation.
For more information, individuals can contact the firm directly through email or phone.
This article was automatically generated by Open AI, and the details within may not be accurate. Requests for removal, retraction, or correction can be sent via email to contact@publiclawlibrary.org.